Dr. Katrin Rübsamen
Katrin's practice is focused on public commercial law, with a particular emphasis on the healthcare sector and life science industry.
Clients who have benefited from her experience, in particular in the hospital, medical devices and pharmaceutical business, include major domestic and international companies as well as international private equity firms. Katrin helps clients to navigate complex national and cross-border projects and transactions with her knowledge on the EU and German legal framework, ensuring that their business operations are fully compliant with all applicable regulations.
Armed with an in-depth knowledge of the regulatory landscape, Katrin also advises public institutions, banks and insurance companies on regulatory and corporate as well as product-related issues in the financial services sector.
Katrin's advise regularly involves constitutional and EU law issues.
Nordic Capital Fund IX, 2018
Advised Nordic Capital on the acquisition of Prospitalia GmbH, a leading healthcare-spend management and technology-enabled clinical solutions company for acute, post-acute and other healthcare service providers and vendors.
Nordic Capital VIII Ltd, 2017/2018
Advised Nordic Capital on its acquisition of Alloheim from the Carlyle Group. With around 180 homes, Alloheim is Germany’s second largest operator of nursing homes.
Zur Rose Group AG / Doc Morris, 2017 / 2018
Advised Swiss Zur Rose on its IPO with a volume of approx. 252 Mio. Swiss Franc and DocMorris Holding GmbH on its acquisition of the mail order pharmacy Vitalsana.
IK Investment Partners, 2017
Representation of IK on the acquisition of the business division of GHD GesundHeits GmbH Deutschland, Profusio, the second largest compounder of cytostatics in Germany.
Advised Ardian in the acquisition of a majority stake in SCHWIND eye-tech-solutions GmbH & Co. KG, one of the world‘s leading specialists in laser systems for the treatment of refractive errors and corneal diseases. The company's products are available in 125 countries worldwide.
IK Investment Partners, 2016
Representation of IK, the Sweden-based private equity investor, in the acquisition of ZytoService Deutschland GmbH, a leading compounder of pharmaceuticals for patient-individualised infusions, from the founders and Capiton by IK VIII Fund.
Duke Street, 2016
Advised Duke Street on its acquisition of Medi-Globe, a Germany-based medical devices business focused on minimally invasive surgery in gastroenterology and urology and distribution of a wide range of hospital supplies to an expanding range of customers.
Nordic Capital, 2015
Advised Nordic Capital on the acquisition of the Sunrise Medical group, a world leader in the development, manufacture and distribution of wheelchairs, from Equistone Partners Europe.
Nordic Capital, 2014
Advised Nordic Capital on the acquisition of GHD Gesundheits GmbH Deutschland, Germany's market leader for homecare services including the production of medical supplies and compounded pharmaceuticals.
Korian-Medica S.A. / Curanum AG, 2014 / 2015
Representation of Korian-Medica S.A., market leader in the European Ageing Well sector, and its daughter company on the acquisition of several operators of nursing homes and a hospital service provider from various sellers in Germany.
Samsung Electronics GmbH, 2012
Advised Samsung Electronics GmbH on the acquisition of Sonoace Deutschland GmbH, an ultrasound equipment manufacturer. This challenging mandate involved advice on the regulatory requirements for medical devices, and the requirements associated with the sale of ultrasound equipment. Ongoing advice to Samsung’s business unit Health Medical Equipment on, inter alia, regulatory requirements, healthcare compliance and data protection.
"Banking Union and Deposit Guarantee Scheme – Compensation, Alternative Measures and Financing", November 11, 2014: Association of German Banks (Bankenunion und Einlagensicherung – Entschädigung, alternative Maßnahmen und Finanzierung)
Legal Framework applicable to mobileHealth (Rechtliche Rahmenbedingungen für mobileHealth), MedR, Issue 7, pp 485-491, 2015
Legal Limits to Cooperation between the Medical Device Industry and Health Care Institutions (Rechtliche Grenzen der Kooperationen zwischen Medizinprodukteindustrie und medizinischen Einrichtungen), MedR, Issue 3, pp.152-157, 2014
Bundesbank Act, Nomos-Commentary. The German Federal Law (Bundesbankgesetz, Nomos-Kommentar. Das deutsche Bundesrecht), Baden-Baden, Loose Leaf System, Status, June 2014, (co-author with Henning Berger)
Constitutional Limits of Reviews by Courts of Processing Fee Clauses in Consumer Loan Agreements (Verfassungsrechtliche Grenzen der gerichtlichen Kontrolle von Klauseln über Bearbeitungsentgelte in Verbraucherkreditverträgen), WM, Issue 40, pp.1877-1924, 2011, (co-author with Henning Berger)
Constitutional aspects of hospital-financing based on diagnosis related groups (Verfassungsrechtliche Aspekte des Fallpauschalensystems im Krankenhauswesen (DRG-System)), Dissertation, Baden-Baden, 2008